International Stem Cell Stock Analysis
| ISCO Stock | USD 0.10 0.01 9.09% |
International Stem Cell is overvalued with Real Value of 0.082 and Hype Value of 0.1. The main objective of International Stem otc analysis is to determine its intrinsic value, which is an estimate of what International Stem Cell is worth, separate from its market price. There are two main types of International Stem's stock analysis: fundamental analysis and technical analysis.
The International Stem otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
International |
International OTC Stock Analysis Notes
About 54.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 103.12. International Stem Cell recorded a loss per share of 0.04. The entity had not issued any dividends in recent years. The firm had 1:150 split on the 29th of July 2015. International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California. International Stem operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 26 people.The quote for International Stem Cell is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about International Stem Cell call Andrey Semechkin at 760 940 6383 or check out https://www.internationalstemcell.com.International Stem Cell Investment Alerts
| International Stem is way too risky over 90 days horizon | |
| International Stem has some characteristics of a very speculative penny stock | |
| International Stem appears to be risky and price may revert if volatility continues | |
| International Stem has high likelihood to experience some financial distress in the next 2 years | |
| International Stem Cell currently holds 4.31 M in liabilities. International Stem Cell has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist International Stem until it has trouble settling it off, either with new capital or with free cash flow. So, International Stem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like International Stem Cell sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for International to invest in growth at high rates of return. When we think about International Stem's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 7.18 M. Net Loss for the year was (899 K) with profit before overhead, payroll, taxes, and interest of 4.24 M. | |
| International Stem Cell currently holds about 586 K in cash with (1.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07. | |
| Roughly 54.0% of the company shares are held by company insiders |
International Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate International Stem's market, we take the total number of its shares issued and multiply it by International Stem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.International Profitablity
International Stem's profitability indicators refer to fundamental financial ratios that showcase International Stem's ability to generate income relative to its revenue or operating costs. If, let's say, International Stem is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, International Stem's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of International Stem's profitability requires more research than a typical breakdown of International Stem's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07. Technical Drivers
As of the 27th of December, International Stem retains the Market Risk Adjusted Performance of 1.62, risk adjusted performance of 0.111, and Downside Deviation of 28.74. International Stem technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to break down nineteen technical drivers for International Stem Cell, which can be compared to its competitors.International Stem Cell Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. International Stem middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for International Stem Cell. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
International Stem Outstanding Bonds
International Stem issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. International Stem Cell uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most International bonds can be classified according to their maturity, which is the date when International Stem Cell has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
International Stem Predictive Daily Indicators
International Stem intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of International Stem otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.91 | |||
| Day Median Price | 0.1 | |||
| Day Typical Price | 0.1 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
International Stem Forecast Models
International Stem's time-series forecasting models are one of many International Stem's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary International Stem's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About International OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how International Stem prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling International shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as International Stem. By using and applying International OTC Stock analysis, traders can create a robust methodology for identifying International entry and exit points for their positions.
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California. International Stem operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 26 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding International Stem to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Other Information on Investing in International OTC Stock
International Stem financial ratios help investors to determine whether International OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Stem security.